Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
about
Genetic determinants and potential therapeutic targets for pancreatic adenocarcinomaInteraction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammalsPurified human BRCA2 stimulates RAD51-mediated recombinationIdentification of a founder BRCA2 mutation in SardiniaThe BRCA2 gene product functionally interacts with p53 and RAD51Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityStudy of a single BRCA2 mutation with high carrier frequency in a small populationBRCA1 and BRCA2 mutations in central and southern Italian patients.Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers.Haplotype analysis suggest common founders in carriers of the recurrent BRCA2mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer familiesPALB2: the hub of a network of tumor suppressors involved in DNA damage responsesGenetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage ConsortiumHigh risk factors of pancreatic carcinoma.A novel BRCA2 mutation in an Indonesian family found with a new, rapid, and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing.Origin and distribution of the BRCA2-8765delAG mutation in breast cancerPancreatic adenocarcinoma: epidemiology and genetics.Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genesManaging hereditary ovarian cancer risk.Genetic predisposition to breast cancer: a surgical perspective.Inherited predisposition to pancreatic cancer.Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancerThe role of genetic factors in the etiology of pancreatic adenocarcinoma: an update.Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancerCancer risks in BRCA2 mutation carriers.Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts.Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.A low proportion of BRCA2 mutations in Finnish breast cancer families.Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2.Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?Elevated cancer mortality in the relatives of patients with pancreatic cancer.Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancerGene therapy for carcinoma of the breast.Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implicationsGenetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.Role of BRCA1 and BRCA2 mutations in pancreatic cancer.Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma
P2860
Q21129230-D05B07F7-2E49-4BBC-AB64-BEF6CD47DE50Q22010135-A996F009-190F-4700-9C64-A56D9B39094FQ24297031-C8A111F0-A4DB-4364-8DDD-E85F649903B0Q24649532-EA4D133F-52ED-42B2-A669-D006033C3D22Q24650406-FAA4BB7F-AD3A-4080-A17E-7070BA71832EQ24679438-E15C6CC7-87F7-4BA7-82F4-D0203E09737CQ24680535-50FE8D08-799E-4D3C-A901-83B1F34DAC33Q24791292-EA2B899D-03DF-44B7-A6E9-D3DF46337CACQ24803349-EF880C64-D40D-4D29-B01A-ECB54E064CBAQ27496673-C27E89AF-7824-43D6-8F8A-AA81AA2B27ACQ28243398-AA60DEAF-4214-4079-9AEA-D9BEDB6116FBQ29619206-28117DCC-B341-4665-A28B-580E91290AA2Q30249161-2475F5B8-697E-457D-B3A9-26E6BE66D069Q33214483-18940322-1179-4E11-B033-42D7AB7FE9BDQ33291268-72454B84-D9F6-42E8-A14D-790FBF2433ACQ33677968-E7863F5A-0269-4E77-AB44-3F57BCA817CBQ33680173-45B7B1D3-6961-4461-AB63-5592DE288AC9Q33813990-C106FFC8-97E0-4E2B-98F8-36B353171F70Q33836065-F28BBC69-38DA-43BA-BC73-66B4E429CA7FQ33931174-544E13DD-1ABE-4149-A033-415E8B26CF7DQ34113283-C57AED25-4D53-4405-930B-E60AD399ADACQ34211033-364F6EA8-ADA9-49BB-A0A4-775EF5CE6835Q34335398-A960AA2E-1397-4BEC-98C3-3180794A976AQ34387715-915B6254-60BA-445D-8685-E2916DCA6B64Q34417238-449E630D-60AD-4F9C-AE67-780C6E3F375CQ34504452-7878979E-6389-4C82-B13B-72B3C9901522Q34960835-07A68ED6-F77A-4E1C-8FB7-E17AE72E56B6Q35238410-B216AD65-1971-479E-9BD9-67C0DED7F7F5Q35238446-1C68E674-AF1E-4CF3-95CE-E20AD7F8F483Q35238455-DFFAED19-28E1-42DE-8B4C-B7B2CCC4076FQ35238541-3375EAB9-2174-4D3C-A336-8563BDEA2A57Q35238904-2CE1F828-201B-4E8E-93FF-47581986EBF5Q35308706-731D69E0-6BD5-4E7E-AC8C-FFC9701B9F0CQ35594607-5A3B5113-232B-4A39-9B5A-91EADDE97E22Q35609061-FCF12242-63BE-4D07-9B85-6F541B4CB703Q35790591-BD966664-ADF5-4F71-B0B8-905360FB5461Q35810230-6616F53E-907B-4B63-AB36-28602DE50AD5Q35882332-D4FA6BE3-C2FD-46C0-99A2-DC6F41DAFF3FQ35929538-67E21142-3637-4D06-860A-C78704840621Q36431503-380774CA-DA4F-425B-A78A-5CE2E1817907
P2860
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
@en
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
@nl
type
label
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
@en
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
@nl
prefLabel
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
@en
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
@nl
P2093
P2860
P50
P356
P1433
P1476
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
@en
P2093
Anderson D
Faucher MC
Ghadirian P
P2860
P2888
P304
P356
10.1038/NG0596-120
P407
P577
1996-05-01T00:00:00Z
P5875
P6179
1013763197